IN191835B - - Google Patents

Info

Publication number
IN191835B
IN191835B IN829DE2001A IN191835B IN 191835 B IN191835 B IN 191835B IN 829DE2001 A IN829DE2001 A IN 829DE2001A IN 191835 B IN191835 B IN 191835B
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Yatendra Kumar
Mohan Prasad
Praveen Kumar Neela
Misra Satyananda
Original Assignee
Ranbaxy Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Lab Ltd filed Critical Ranbaxy Lab Ltd
Priority to IN829DE2001 priority Critical patent/IN191835B/en
Priority to CNA028171594A priority patent/CN1571767A/zh
Priority to PL02368600A priority patent/PL368600A1/xx
Priority to EP02755412A priority patent/EP1419135A4/en
Priority to PCT/IB2002/003012 priority patent/WO2003014060A1/en
Priority to BR0211691-0A priority patent/BR0211691A/pt
Priority to CA002456293A priority patent/CA2456293A1/en
Priority to US10/485,585 priority patent/US6822119B1/en
Publication of IN191835B publication Critical patent/IN191835B/en
Priority to NO20040482A priority patent/NO20040482L/no
Priority to ZA200400999A priority patent/ZA200400999B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/02—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions involving the formation of amino groups from compounds containing hydroxy groups or etherified or esterified hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
IN829DE2001 2001-08-03 2001-08-03 IN191835B (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
IN829DE2001 IN191835B (ja) 2001-08-03 2001-08-03
CNA028171594A CN1571767A (zh) 2001-08-03 2002-08-02 托特罗定的制备方法
PL02368600A PL368600A1 (en) 2001-08-03 2002-08-02 Process for the preparation of tolterodine
EP02755412A EP1419135A4 (en) 2001-08-03 2002-08-02 PROCESS FOR THE PREPARATION OF TOLTERODINE
PCT/IB2002/003012 WO2003014060A1 (en) 2001-08-03 2002-08-02 Process for the preparation of tolterodine
BR0211691-0A BR0211691A (pt) 2001-08-03 2002-08-02 Processo para a prepara de tolterodina
CA002456293A CA2456293A1 (en) 2001-08-03 2002-08-02 Process for the preparation of tolterodine
US10/485,585 US6822119B1 (en) 2001-08-03 2002-08-02 Process for the preparation of tolterodine
NO20040482A NO20040482L (no) 2001-08-03 2004-02-03 Fremgangsmåte til fremstilling av tolterodin.
ZA200400999A ZA200400999B (en) 2001-08-03 2004-02-06 Process for the preparation of tolterodine.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN829DE2001 IN191835B (ja) 2001-08-03 2001-08-03

Publications (1)

Publication Number Publication Date
IN191835B true IN191835B (ja) 2004-01-10

Family

ID=11097097

Family Applications (1)

Application Number Title Priority Date Filing Date
IN829DE2001 IN191835B (ja) 2001-08-03 2001-08-03

Country Status (10)

Country Link
US (1) US6822119B1 (ja)
EP (1) EP1419135A4 (ja)
CN (1) CN1571767A (ja)
BR (1) BR0211691A (ja)
CA (1) CA2456293A1 (ja)
IN (1) IN191835B (ja)
NO (1) NO20040482L (ja)
PL (1) PL368600A1 (ja)
WO (1) WO2003014060A1 (ja)
ZA (1) ZA200400999B (ja)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1603862A1 (en) * 2003-03-06 2005-12-14 Ranbaxy Laboratories Limited 3,3-diarylpropylamine derivatives and processes for isolation thereof
ES2235648B1 (es) * 2003-12-22 2006-11-01 Ragactives, S.L. Procedimiento para la obtencion de tolterodina.
EP1629834A1 (en) 2004-08-27 2006-03-01 KRKA, D.D., Novo Mesto Sustained release pharmaceutical composition of tolterodine
ITMI20041920A1 (it) * 2004-10-11 2005-01-11 Chemi Spa Processo per la preparazione di n, n-diisopropil-3-2-idrossi-5-metilfenil-3-fenil-propabammina
US7355077B2 (en) * 2004-10-28 2008-04-08 Dr. Reddy's Laboratories Limited Process for preparing tolterodine
JP4513535B2 (ja) * 2004-12-03 2010-07-28 住友化学株式会社 トルテロジンの製造方法
CA2590555A1 (en) * 2005-01-10 2006-07-13 Teva Pharmaceutical Industries Ltd. Substantially pure tolterodine tartrate and process for preparing thereof
ES2268987B1 (es) 2005-08-05 2008-02-01 Ragactives, S.L. Procedimiento para la obtencion de 3,3-difenilpropilaminas.
KR100647068B1 (ko) 2005-09-15 2006-11-23 하나제약 주식회사 라세믹ｎ,ｎ-디이소프로필-3-(2-히드록시-5-메틸페닐)-3-페닐프로판아민의 제조방법
KR100686351B1 (ko) * 2006-01-12 2007-02-22 주식회사 카이로제닉스 톨테로딘 라세미체의 제조방법
US7268257B1 (en) 2006-05-31 2007-09-11 Sumitomo Chemical Company, Limited Process for producing tolterodine
MXPA06007686A (es) * 2006-07-04 2008-01-07 Uquifa Mexico S A De C V Proceso para la obtencion del tartrato de tolterodina.
EP2175843B1 (en) 2007-08-08 2014-10-08 Inventia Healthcare Private Limited Extended release compositions comprising tolterodine
WO2010092500A2 (en) * 2009-02-12 2010-08-19 Alembic Limited A process for the preparation of tolterodine tartrate
WO2010094292A1 (en) * 2009-02-17 2010-08-26 Pharmathen S.A. Improved process for the preparation of (r)-2-(3-diisopropylamino)-1-phenylpropyl)-4methylphenol and salts thereof
WO2012098044A1 (en) 2011-01-17 2012-07-26 Cambrex Profarmaco Milano S.R.L. Process for the preparation of n,n-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
EP2476665A1 (en) 2011-01-17 2012-07-18 Cambrex Profarmaco Milano S.r.l. Process for the preparation of N,N-diisopropyl-3-(2-hydroxy-5-methylphenyl)- 3-phenyl propylamine and its salts starting from a novel intermediate
CN104628552A (zh) * 2015-02-09 2015-05-20 许昌豪丰化学科技有限公司 一种新淬灭体系及其应用
CN114213265A (zh) * 2021-12-22 2022-03-22 南京美瑞制药有限公司 一种制备托特罗定氧化杂质的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5382600A (en) * 1988-01-22 1995-01-17 Pharmacia Aktiebolag 3,3-diphenylpropylamines and pharmaceutical compositions thereof
KR20000057548A (ko) * 1996-12-13 2000-09-25 알프레드 엘. 미첼슨 광학적 전송물질 및 결합재

Also Published As

Publication number Publication date
BR0211691A (pt) 2004-11-09
PL368600A1 (en) 2005-04-04
CN1571767A (zh) 2005-01-26
NO20040482L (no) 2004-03-29
US20040249211A1 (en) 2004-12-09
ZA200400999B (en) 2004-05-20
US6822119B1 (en) 2004-11-23
WO2003014060A1 (en) 2003-02-20
CA2456293A1 (en) 2003-02-20
EP1419135A1 (en) 2004-05-19
EP1419135A4 (en) 2006-01-11

Similar Documents

Publication Publication Date Title
BE2014C052I2 (ja)
BE2014C026I2 (ja)
BE2014C004I2 (ja)
BE2014C006I2 (ja)
BE2012C050I2 (ja)
BE2012C022I2 (ja)
BE2011C034I2 (ja)
BE2007C047I2 (ja)
AU2002307149A8 (ja)
JP2001245898A5 (ja)
IN205622B (ja)
BE2016C043I2 (ja)
HU0202334D0 (ja)
BE2014C008I2 (ja)
JP2002038903A5 (ja)
CH1379220H1 (ja)
IN2004CH00782A (ja)
IN191835B (ja)
JP2002033823A5 (ja)
JP2002242983A5 (ja)
JP2002168535A5 (ja)
IN2004DE00304A (ja)
BRPI0210463A2 (ja)
JP2002230976A5 (ja)
AU2000280389A8 (ja)